Marin-Garcia J, Goldenthal M J, Ananthakrishnan R, Pierpont M E
Molecular Cardiology Institute, Highland Park, New Jersey 08904, USA.
J Card Fail. 2000 Dec;6(4):321-9. doi: 10.1054/jcaf.2000.19232.
Previous studies have shown that mitochondrial DNA (mtDNA) mutations are often present in patients with myocardial dysfunction. We sought to assess the prevalence and significance of heart mtDNA sequence changes in patients with idiopathic dilated cardiomyopathy (DCM).
DNA sequence of all the transfer ribonucleic acid (tRNA), ribosomal RNA (rRNA), and structural genes in cardiac mtDNA of 28 patients with DCM was determined and compared with a control group that had no evidence of heart disease. An increased number of point mutations were found in DCM cardiac mtDNA when compared with controls. Both novel and previously reported mutations were found in mitochondrial tRNA and structural genes. One of these mutations was heteroplasmic and resulted in changing a highly conserved nucleotide in tRNAArg. Novel, heteroplasmic mtDNA mutations (n = 4) specifying changes in moderate to highly conserved amino acid residues were found in COII, COIII, ND5, and cytb. These novel mtDNA mutations were found only in patients with severe reduction in mitochondrial enzyme activities.
Our results indicate that a high incidence of mtDNA nucleotide sequence changes in both tRNA and structural genes are present in DCM. Five heteroplasmic mutations were detected that both changed evolutionarily conserved residues (which may impair the function of proteins or tRNAs) and were associated with specific enzymatic defects. These mutations could play an important role in the pathogenesis of cardiomyopathy.
既往研究表明,线粒体DNA(mtDNA)突变常出现在心肌功能障碍患者中。我们试图评估特发性扩张型心肌病(DCM)患者心脏mtDNA序列变化的发生率及意义。
测定了28例DCM患者心脏mtDNA中所有转运核糖核酸(tRNA)、核糖体RNA(rRNA)和结构基因的DNA序列,并与无心脏病证据的对照组进行比较。与对照组相比,发现DCM心脏mtDNA中的点突变数量增加。在线粒体tRNA和结构基因中均发现了新的和先前报道的突变。其中一个突变是异质性的,导致tRNAArg中一个高度保守的核苷酸发生改变。在细胞色素氧化酶亚基II(COII)、细胞色素氧化酶亚基III(COIII)、烟酰胺腺嘌呤二核苷酸脱氢酶亚基5(ND5)和细胞色素b(cytb)中发现了新的异质性mtDNA突变(n = 4),这些突变导致中度至高度保守氨基酸残基发生改变。这些新的mtDNA突变仅在线粒体酶活性严重降低的患者中发现。
我们的结果表明,DCM患者的tRNA和结构基因中mtDNA核苷酸序列变化的发生率很高。检测到五个异质性突变,这些突变既改变了进化保守残基(可能损害蛋白质或tRNA的功能),又与特定的酶缺陷相关。这些突变可能在心肌病的发病机制中起重要作用。